Skip to content

Clinical trials

Phase 2 Eczema trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Eczema Phase: Phase 2 Country / region: Australia Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20141
20151
20192
20211
20223
20231
20242
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting4
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Evelo Biosciences, Inc.2
ASLAN Pharmaceuticals1
Alphyn Biologics1
Amgen1
AstraZeneca1
Evommune, Inc.1
Inmagene LLC1
Kymab Limited1
MedImmune LLC1
National Institute of Allergy and Infectious Diseases (NIAID)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Eczema15
Dermatitis, Atopic14
Dermatitis3
Asthma1
Food Hypersensitivity1
Hypersensitivity1
Immune System Diseases1
Inflammation1
Skin Diseases1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.